Search Results - "RUYMANN, F. B"

Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease by CRIST, William M, ANDERSON, James R, LOBE, Thom, WEBBER, Bruce, MAURER, Harold M, DONALDSON, Sarah S, MEZA, Jane L, FRYER, Christopher, RANEY, R. Beverly, RUYMANN, Frederick B, BRENEMAN, John, QUALMAN, Stephen J, WIENER, Eugene, WHARAM, Moody

“…The study goal was to improve outcome in children with rhabdomyosarcoma by comparing risk-based regimens of surgery, radiotherapy (RT) and chemotherapy. Eight…”
Get full text

The national cancer data base report on patterns of childhood cancers in the United States by Grovas, Alfred, Fremgen, Amy, Rauck, Amanda, Ruymann, Frederick B., Hutchinson, Carol L., Winchester, David P., Menck, Herman R.

“…BACKGROUND Patterns of and progress against childhood cancer have been reported on multi‐institution, regional, national, and international bases by several…”
Get full text

Second Neoplasms after Acute Lymphoblastic Leukemia in Childhood by Neglia, Joseph P, Meadows, Anna T, Robison, Leslie L, Kim, Tae H, Newton, William A, Ruymann, Frederick B, Sather, Harland N, Hammond, G. Denman

“…THE ability to cure acute lymphoblastic leukemia (ALL) occurring in childhood is regarded as one of the landmark developments of the past 30 years in cancer…”
Get full text

Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213 by WELLS, R. J, ARTHUR, D. C, BETCHER, D. L, BUCKLEY, J. D, FEIG, S. A, KIM, T, ODOM, L. F, RUYMANN, F. B, SMITHSON, W. A, TANNOUS, R, WHITT, J. K, WOLFF, L, SRIVASTAVA, A, TJOA, T, LAMPKIN, B. C, HEEREMA, N. A, LE BEAU, M, ALONZO, T. A, BUXTON, A. B, WOODS, W. G, HOWELLS, W. B, BENJAMIN, D. R

“…The objective of this study was to identify biologic parameters that were associated with either exceptionally good or poor outcome in childhood acute myeloid…”
Get full text

Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects by Yang, P, Grufferman, S, Khoury, M J, Schwartz, A G, Kowalski, J, Ruymann, F B, Maurer, H M

“…Rhabdomyosarcoma (RMS) is an uncommon malignant soft tissue sarcoma whose cause is largely unknown. Reported risk factors include genetic alterations (e.g.,…”
Get more information

Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy by Pendergrass, T W, Milstein, J M, Geyer, J R, Mulne, A F, Kosnik, E J, Morris, J D, Heideman, R L, Ruymann, F B, Stuntz, J T, Bleyer, W A

“…The development of a new multidrug chemotherapy regimen for primary brain tumors was based upon the cellular heterogeneity within individual tumors, the…”
Get more information

Aggressive chemotherapy, organ-preserving surgery, and high-dose-rate remote brachytherapy in the treatment of rhabdomyosarcoma in infants and young children by Nag, S, Grecula, J, Ruymann, F B

“…External beam radiation therapy often is avoided in the treatment of rhabdomyosarcoma (RMS) in young children because of the long-term sequelae. Conventional…”
Get more information

The Third Intergroup Rhabdomyosarcoma Study by Crist, W, Gehan, E A, Ragab, A H, Dickman, P S, Donaldson, S S, Fryer, C, Hammond, D, Hays, D M, Herrmann, J, Heyn, R

“…The ultimate goal of the Third Intergroup Rhabdomyosarcoma Study (IRS-III, 1984 to 1991) was to improve treatment outcome in children with rhabdomyosarcoma…”
Get more information

Neurofibromatosis-Noonan syndrome and acute lymphoblastic leukemia : A report of two cases by KLOPFENSTEIN, K. J, SOMMER, A, RUYMANN, F. B

“…Two boys with neurofibromatosis-Noonan syndrome in whom acute lymphoblastic leukemia (ALL) developed are described. Both patients demonstrated B-lineage…”
Get full text

Mobilization of peripheral blood stem cells in children using G-CSF after carboplatin containing myelosuppressive chemotherapy by Rauck, A. M., Ruymann, F. B., Klopfenstein, K., Grossman, N., Rosselet, R., Grovas, L., Ceselski, S., Hayes, J., Grovas, A. C.

“…PURPOSE Peripheral blood stem cell (PBSC) apheresis provides an alternative to autologous marrow harvest as a source of hematologic stem cells for…”
Get full text

The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma by Stephenson, S R, Cook, B A, Mease, A D, Ruymann, F B

“…Stage IV-S neuroblastoma is a unique disseminated neoplasia characterized by remote disease to the liver, skin, or bone marrow. Stage IV-S patients have…”
Get more information

Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response by Ruymann, F B, Vietti, T, Gehan, E, Wiener, E, Wharam, M, Newton, Jr, W A, Maurer, H

“…The Intergroup Rhabdomyosarcoma Study (IRS) initiated an escalating-dose cyclophosphamide (Cyc) pilot without hematopoietic growth factor (HGF) support in…”
Get more information

Pharmacokinetics and safety of prochlorperazine in paediatric patients receiving cancer chemotherapy by Nahata, M C, Ford, C, Ruymann, F B

“…Nausea and vomiting are common clinical problems in patients receiving cancer chemotherapy. Metoclopramide is often used but frequently causes extrapyramidal…”
Get more information

A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study by Steuber, C P, Civin, C, Krischer, J, Culbert, S, Ragab, A, Ruymann, F B, Ravindranath, Y, Leventhal, B, Wilkinson, R, Vietti, T J

“…Two hundred fifty-six children with previously untreated acute nonlymphocytic leukemia (ANLL) were evaluated on a Pediatric Oncology Group (POG) phase III…”
Get more information

Variables influencing end-of-life care in children and adolescents with cancer by KLOPFENSTEIN, Kathryn J, HUTCHISON, Carol, CLARK, Carlee, YOUNG, Donn, RUYMANN, Frederick B

“…The purpose of this study was to describe the variables influencing end-of-life care in children and adolescents dying of cancer. Records of 146 children with…”
Get full text

Intraoperative high-dose-rate brachytherapy for the treatment of pediatric tumors: the Ohio State University experience by Nag, S, Tippin, D, Ruymann, F B

“…To determine whether intraoperative high-dose-rate brachytherapy (IO-HDRBT) can be used to decrease the dose of external beam radiotherapy (EBRT) in the…”
Get more information

The Intergroup Rhabdomyosarcoma Study-II by Maurer, H M, Gehan, E A, Beltangady, M, Crist, W, Dickman, P S, Donaldson, S S, Fryer, C, Hammond, D, Hays, D M, Herrmann, J

“…Intergroup Rhabdomyosarcoma Study (IRS)-II, (1978-1984) had the general goals of improving the survival and treatment of children with rhabdomyosarcoma (RMS)…”
Get more information

The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia by Woods, W G, Ruymann, F B, Lampkin, B C, Buckley, J D, Bernstein, I D, Srivastava, A K, Smithson, W A, Benjamin, D R, Feig, S A, Kim, T H

“…The Children's Cancer Study Group instituted a pilot study to investigate the use of high doses of cytosine arabinoside (AraC) in the intensification phase of…”
Get more information

Rhabdomyosarcoma of the biliary tree in childhood. A report from the Intergroup Rhabdomyosarcoma Study by Ruymann, F B, Raney, Jr, R B, Crist, W M, Lawrence, Jr, W, Lindberg, R D, Soule, E H

“…Ten cases of rhabdomyosarcoma of the biliary tree (RMS/BT) in children are reported in this review of the Intergroup Rhabdomyosarcoma Study (IRS) I and II…”
Get more information

Progress in the Diagnosis and Treatment of Rhabdomyosarcoma and Related Soft Tissue Sarcomas by Ruymann, Frederick B., Grovas, Alfred C.

“…Abstract Advances in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas continue in the Intergroup Rhabdomyosarcoma Study Group…”
Get full text